Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2000

View Archived Issues

Mycophenolic acid reduces HIV viral replication

Fas gene highlighted in hepatitis research

Research reveals new gene target for osteoporosis treatment

Peruvian plants found to be active against tuberculosis

NIH licensing opportunity: radiation therapy optimization technology

Combination antiviral therapies offered for licensing by NIH

Diatide's radiodiagnostic receives positive opinion for E.U. approval

Newly issued patents cover related series of novel amides

British Biotech partners with De Novo for antibacterial drug discovery

Novel VLA-4 inhibitors reported by Elan and Wyeth-Ayerst

Kinase inhibitors demonstrate apoptotic activity in chronic lymphocytic leukemia

Protein levels indicate severity of prostate cancer tumors

Vivelle receives FDA approval for prevention of osteoporosis

Efficacy of endothelin receptor antagonists in chronic heart failure compared

Highly selective m4 muscarinic receptor antagonist described

In vivo results presented for PARP inhibitor GPI-6150

Abbott describes novel selective MMP-2/MMP-9 inhibitors

Analgesic agents under development at Meiji Seika

Kyorin receives patent for new series of AMPA antagonists

New VLA-4 inhibitors under development at Aventis

NIH awards Epimmune grant for HIV-1 vaccine development

Aronex's amended Atragen NDA accepted for FDA review

Chiron to acquire PathoGenesis; TOBI clears E.U. mutual recognition process

Seven key sessions and symposia from XXII ESC Congress available to Daily Essentials readers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...